PELI Logo
title

References - Advanced nutritional support for healing and protecting the gastrointestinal tract

  1. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009 Jul;124(1):3-22. DOI: 10.1016/j.jaci.2009.05.038
  2. Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, De Souza HSP. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. 2022 Mar;23(7):3464. DOI: 10.3390/ijms23073464
  3. Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int J Mol Sci. 2021 Jun;22(12):6242. DOI: 10.3390/ijms22126242
  4. An J, Liu Y, Wang Y, Fan R, Hu X, Zhang F, et al. The role of intestinal mucosal barrier in autoimmune disease: a potential target. Front Immunol. 2022;13:871713. DOI: 10.3389/fimmu.2022.871713
  5. Moludi J, Maleki V, Jafari-Vayghyan H, Vaghef-Mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: a systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol. 2020 Jun;47(6):927-939. DOI: 10.1111/1440-1681.13250
  6. Salguero MV, Al-Obaide MAI, Singh R, Siepmann T, Vasylyeva TL. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019 Nov;18(5):3461-3469. DOI: 10.3892/etm.2019.7943
  7. Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, et al. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer's disease. J Alzheimers Dis. 2020;78(2):683-697. DOI: 10.3233/JAD-200306
  8. Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023 Apr;90:104527. DOI: 10.1016/j.ebiom.2023.104527
  9. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008 Feb;29(1):117-124.
  10. Oriá RB, Murray-Kolb LE, Scharf RJ, Pendergast LL, Lang DR, Kolling GL, et al. Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children. Nutr Rev. 2016 Jun;74(6):374-386. DOI: 10.1093/nutrit/nuw008
  11. Ronan V, Yeasin R, Claud EC. Childhood development and the microbiome-the intestinal microbiota in maintenance of health and development of disease during childhood development. Gastroenterology. 2021 Jan;160(2):495-506. DOI: 10.1053/j.gastro.2020.08.065
  12. Sarkar A, Yoo JY, Valeria Ozorio Dutra S, Morgan KH, Groer M. The association between early-life gut microbiota and long-term health and diseases. J Clin Med. 2021 Jan;10(3):459. DOI: 10.3390/jcm10030459
  13. Martel J, Chang SH, Ko YF, Hwang TL, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022 Apr;33(4):247-265. DOI: 10.1016/j.tem.2022.01.002
  14. Martel J, Chang SH, Ko YF, Hwang TL, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022 Apr;33(4):247-265. DOI: 10.1016/j.tem.2022.01.002
  15. Kim JM. Antimicrobial proteins in intestine and inflammatory bowel diseases. Intest Res. 2014 Jan;12(1):20-33. DOI: 10.5217/ir.2014.12.1.20
  16. Santos GM, Ismael S, Morais J, Araújo JR, Faria A, Calhau C, et al. Intestinal alkaline phosphatase: a review of this enzyme role in the intestinal barrier function. Microorganisms. 2022 Mar;10(4):746. DOI: 10.3390/microorganisms10040746
  17. Estaki M, DeCoffe D, Gibson DL. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. World J Gastroenterol. 2014 Nov;20(42):15650-15656. DOI: 10.3748/wjg.v20.i42.15650
  18. Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, De Souza HSP. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. 2022 Mar;23(7):3464. DOI: 10.3390/ijms23073464
  19. Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int J Mol Sci. 2021 Jun;22(12):6242. DOI: 10.3390/ijms22126242
  20. Moludi J, Maleki V, Jafari-Vayghyan H, Vaghef-Mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: a systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol. 2020 Jun;47(6):927-939. DOI: 10.1111/1440-1681.13250
  21. Salguero MV, Al-Obaide MAI, Singh R, Siepmann T, Vasylyeva TL. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease. Exp Ther Med. 2019 Nov;18(5):3461-3469. DOI: 10.3892/etm.2019.7943
  22. Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, et al. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer's disease. J Alzheimers Dis. 2020;78(2):683-697. DOI: 10.3233/JAD-200306
  23.  Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023 Apr;90:104527. DOI: 10.1016/j.ebiom.2023.104527
  24. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. 2008 Feb;29(1):117-124.
  25. Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, et al. Glutamine and intestinal barrier function. Amino Acids. 2015 Oct;47(10):2143-2154. DOI: 10.1007/s00726-014-1773-4
  26. Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease. Am J Physiol Gastrointest Liver Physiol. 2020 Nov;319(5):G589-G608. DOI: 10.1152/ajpgi.00245.2020
  27. Wang ZE, Wu D, Zheng LW, Shi Y, Wang C, Chen ZH, et al. Effects of glutamine on intestinal mucus barrier after burn injury. Am J Transl Res. 2018;10(11):3833-3846.
  28. Wu M, Xiao H, Liu G, Chen S, Tan B, Ren W, et al. Glutamine promotes intestinal SIgA secretion through intestinal microbiota and IL-13. Mol Nutr Food Res. 2016 Jul;60(7):1637-1648. DOI: 10.1002/mnfr.201600026
  29. Kim MH, Kim H. The roles of glutamine in the intestine and its implication in intestinal diseases. Int J Mol Sci. 2017 May;18(5):1051. DOI: 10.3390/ijms18051051
  30. Coëffier M, Marion R, Ducrotté P, Déchelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr. 2003 Aug;22(4):407-413. DOI: 10.1016/s0261-5614(03)00040-2
  31. Ann JY, Kim SJ, Han SP, Kim JW, Kim HJ, Do JH, et al. [Effect of glutamine on the non-steroidal anti-inflammatory drug-induced bacterial translocation]. Korean J Gastroenterol. 2004 Nov;44(5):252-258.
  32. Mitra R, Pal SP. Inhibition of mast cell population by L-glutamine in aspirin-induced ulceration in rat stomach. Indian J Physiol Pharmacol. 1977;21(4):374-378.
  33. Okabe S, Honda K, Takeuchi K, Takagi K. Inhibitory effect of L-glutamine on gastric irritation and back diffusion of gastric acid in response to aspirin in the rat. Am J Dig Dis. 1975 Jul;20(7):626-631. DOI: 10.1007/BF01071172
  34. Faure M, Mettraux C, Moennoz D, Godin JP, Vuichoud J, Rochat F, et al. Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr. 2006 Jun;136(6):1558-1564. DOI: 10.1093/jn/136.6.1558
  35. Faure M, Moënnoz D, Montigon F, Mettraux C, Breuillé D, Ballèvre O. Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats. J Nutr. 2005 Mar;135(3):486-491. DOI: 10.1093/jn/135.3.486
  36. Mao X, Zeng X, Qiao S, Wu G, Li D. Specific roles of threonine in intestinal mucosal integrity and barrier function. Front Biosci (Elite Ed). 2011 Jun;3(4):1192-1200. DOI: 10.2741/e322
  37. An JM, Kang EA, Han YM, Kim YS, Hong YG, Hah BS, et al. Dietary threonine prevented stress-related mucosal diseases in rats. J Physiol Pharmacol. 2019 Jun;70(3). DOI: 10.26402/jpp.2019.3.14
  38. Nezwek TA, Varacallo M. Physiology, connective tissue [Internet]. Treasure Island: StatPearls; 2022 [cited 2023 Oct 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542226/
  39. Campos LD, Santos Junior VDA, Pimentel JD, Carregã GLF, Cazarin CBB. Collagen supplementation in skin and orthopedic diseases: a review of the literature. Heliyon. 2023 Apr;9(4):e14961. DOI: 10.1016/j.heliyon.2023.e14961
  40. De Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021 Dec;60(12):1449-1461. DOI: 10.1111/ijd.15518
  41. Asserin J, Lati E, Shioya T, Prawitt J. The effect of oral collagen peptide supplementation on skin moisture and the dermal collagen network: evidence from an ex vivo model and randomized, placebo-controlled clinical trials. J Cosmet Dermatol. 2015 Dec;14(4):291-301. DOI: 10.1111/jocd.12174
  42.  Ramadass SK, Jabaris SL, Perumal RK, HairulIslam VI, Gopinath A, Madhan B. Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: a new treatment strategy. Eur J Pharm Sci. 2016 Aug;91:216-224. DOI: 10.1016/j.ejps.2016.05.015
  43. Ramadass SK, Perumal S, Jabaris SL, Madhan B. Preparation and evaluation of mesalamine collagen in situ rectal gel: a novel therapeutic approach for treating ulcerative colitis. Eur J Pharm Sci. 2013 Jan;48(1-2):104-110. DOI: 10.1016/j.ejps.2012.10.015
  44.  Ramadass SK, Perumal S, Jabaris SL, Madhan B. Preparation and evaluation of mesalamine collagen in situ rectal gel: a novel therapeutic approach for treating ulcerative colitis. Eur J Pharm Sci. 2013 Jan;48(1-2):104-110. DOI: 10.1016/j.ejps.2012.10.015
  45.  Efthymakis K, Neri M. The role of zinc L-carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clin Res Hepatol Gastroenterol. 2022;46(7):101954. DOI: 10.1016/j.clinre.2022.101954
  46. Wang X, Valenzano MC, Mercado JM, Zurbach EP, Mullin JM. Zinc supplementation modifies tight junctions and alters barrier function of Caco-2 human intestinal epithelial layers. Dig Dis Sci. 2013 Jan;58(1):77-87. DOI: 10.1007/s10620-012-2328-8
  47. Podany AB, Wright J, Lamendella R, Soybel DI, Kelleher SL. ZnT2-mediated zinc import into Paneth cell granules is necessary for coordinated secretion and Paneth cell function in mice. Cell Mol Gastroenterol Hepatol. 2016 May;2(3):369-383. DOI: 10.1016/j.jcmgh.2015.12.006
  48. Ito M, Shii D, Segami T, Kojima R, Suzuki Y. Preventive actions of N-(3-aminopropionyl)-L-histidinato zinc (Z-103) through increases in the activities of oxygen-derived free radical scavenging enzymes in the gastric mucosa on ethanol-induced gastric mucosal damage in rats. Jpn J Pharmacol. 1992 Jul;59(3):267-274. DOI: 10.1254/jjp.59.267
  49. Cho CH. Protective effects of zinc L-carnosine (Z-103) on reserpine-induced gastric ulceration in rats. Drug Dev Res. 1992;27:61-65. DOI: 10.1002/ddr.430270107
  50. Cho CH, Luk CT, Ogle CW. The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats. Life Sci. 1991;49(23):PL189-94. DOI: 10.1016/0024-3205(91)90321-2
  51. Yoshikawa T, Naito Y, Tanigawa T, Yoneta T, Yasuda M, Ueda S, et al. Effect of zinc-carnosine chelate compound (Z-103), a novel antioxidant, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Free Radic Res Commun. 1991;14(4):289-296. DOI: 10.3109/10715769109088958
  52. Matsukura T, Takahashi T, Nishimura Y, Ohtani T, Sawada M, Shibata K. Characterization of crystalline L-carnosine Zn(II) complex (Z-103), a novel anti-gastric ulcer agent: tautomeric change of imidazole moiety upon complexation. Chem Pharm Bull (Tokyo). 1990 Nov;38(11):3140-3146. DOI: 10.1248/cpb.38.3140
  53. Arakawa T, Satoh H, Nakamura A, Nebiki H, Fukuda T, Sakuma H, et al. Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2. Dig Dis Sci. 1990 May;35(5):559-566. DOI: 10.1007/BF01540402
  54. Ito M, Tanaka T, Suzuki Y. Effect of N-(3-aminopropionyl)-L-histidinato zinc (Z-103) on healing and hydrocortisone-induced relapse of acetic acid ulcers in rats with limited food-intake-time. Jpn J Pharmacol. 1990 Apr;52(4):513-521. DOI: 10.1254/jjp.52.513
  55. Ueki S, Seiki M, Yoneta T, Omata T, Hori Y, Ishikawa M, et al. Effect of Z-103 on compound 48/80-induced gastric lesions in rats. Scand J Gastroenterol Suppl. 1989;162:202-205. DOI: 10.3109/00365528909091161
  56. Ohkawara T, Takeda H, Kato K, Miyashita K, Kato M, Iwanaga T, et al. Polaprezinc (N-(3-aminopropionyl)-L-histidinato zinc) ameliorates dextran sulfate sodium-induced colitis in mice. Scand J Gastroenterol. 2005 Nov;40(11):1321-1327. DOI: 10.1080/00365520510023530
  57. Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion. 1997;58(5):464-468. DOI: 10.1159/000201484
  58. Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S, et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion. 1997;58(5):464-468. DOI: 10.1159/000201484
  59. Arababadi MK, Nosratabadi R, Asadikaram G. Vitamin D and toll like receptors. Life Sci. 2018 Jun;203:105-111. DOI: 10.1016/j.lfs.2018.03.040
  60. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. DOI: 10.3389/fimmu.2014.00461
  61. Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020 Jul;12(7):2097. DOI: 10.3390/nu12072097
  62. Fletcher J, Cooper SC, Ghosh S, Hewison M. The role of vitamin D in inflammatory bowel disease: mechanism to management. Nutrients. 2019 May;11(5):1019. DOI: 10.3390/nu11051019
  63. Lee C, Lau E, Chusilp S, Filler R, Li B, Zhu H, et al. Protective effects of vitamin D against injury in intestinal epithelium. Pediatr Surg Int. 2019 Dec;35(12):1395-1401. DOI: 10.1007/s00383-019-04586-y
  64. He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, et al. Gut epithelial vitamin D receptor regulates microbiota-dependent mucosal inflammation by suppressing intestinal epithelial cell apoptosis. Endocrinology. 2018 Feb;159(2):967-979. DOI: 10.1210/en.2017-00748
  65. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr. 2013 Oct;143(10):1679-1686. DOI: 10.3945/jn.113.180794
  66. Noda S, Yamada A, Tanabe R, Nakaoka K, Hosoi T, Goseki-Sone M. Menaquinone-4 (vitamin K2) up-regulates expression of human intestinal alkaline phosphatase in Caco-2 cells. Nutr Res. 2016 Nov;36(11):1269-1276. DOI: 10.1016/j.nutres.2016.10.001
  67. Haraikawa M, Sogabe N, Tanabe R, Hosoi T, Goseki-Sone M. Vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) induces intestinal alkaline phosphatase gene expression. J Nutr Sci Vitaminol (Tokyo). 2011;57(4):274-279. DOI: 10.3177/jnsv.57.274
  68. Fenn K, Strandwitz P, Stewart EJ, Dimise E, Rubin S, Gurubacharya S, et al. Quinones are growth factors for the human gut microbiota. Microbiome. 2017 Dec;5(1):161. DOI: 10.1186/s40168-017-0380-5
  69. Chatterjee K, Mazumder PM, Sarkar SR, Saha R, Chatterjee A, Sarkar B, et al. Neuroprotective effect of vitamin K2 against gut dysbiosis associated cognitive decline. Physiol Behav. 2023 Oct;269:114252. DOI: 10.1016/j.physbeh.2023.114252
  70. Hu S, Ma Y, Xiong K, Wang Y, Liu Y, Sun Y, et al. Ameliorating effects of vitamin K2 on dextran sulfate sodium-induced ulcerative colitis in mice. Int J Mol Sci. 2023 Feb;24(3):2986. DOI: 10.3390/ijms24032986
  71. Da Silva LM, Pezzini BC, Somensi LB, Bolda Mariano LN, Mariott M, Boeing T, et al. Hesperidin, a citrus flavanone glycoside, accelerates the gastric healing process of acetic acid-induced ulcer in rats. Chem Biol Interact. 2019 Aug;308:45-50. DOI: 10.1016/j.cbi.2019.05.011
  72. Guo K, Ren J, Gu G, Wang G, Gong W, Wu X, et al. Hesperidin protects against intestinal inflammation by restoring intestinal barrier function and up-regulating Treg cells. Mol Nutr Food Res. 2019 Jun;63(11):e1800975. DOI: 10.1002/mnfr.201800975
  73. Estruel-Amades S, Massot-Cladera M, Pérez-Cano FJ, Franch À, Castell M, Camps-Bossacoma M. Hesperidin effects on gut microbiota and gut-associated lymphoid tissue in healthy rats. Nutrients. 2019 Feb;11(2):324. DOI: 10.3390/nu11020324
  74. Guo K, Ren J, Gu G, Wang G, Gong W, Wu X, et al. Hesperidin protects against intestinal inflammation by restoring intestinal barrier function and up-regulating Treg cells. Mol Nutr Food Res. 2019 Jun;63(11):e1800975. DOI: 10.1002/mnfr.201800975
  75. Crespo ME, Gálvez J, Cruz T, Ocete MA, Zarzuelo A. Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Med. 1999 Oct;65(7):651-653. DOI: 10.1055/s-2006-960838
  76.  Da Silva LM, Pezzini BC, Somensi LB, Bolda Mariano LN, Mariott M, Boeing T, et al. Hesperidin, a citrus flavanone glycoside, accelerates the gastric healing process of acetic acid-induced ulcer in rats. Chem Biol Interact. 2019 Aug;308:45-50. DOI: 10.1016/j.cbi.2019.05.011
  77.  Elshazly SM, Abd El Motteleb DM, Ibrahim IAAEH. Hesperidin protects against stress induced gastric ulcer through regulation of peroxisome proliferator activator receptor gamma in diabetic rats. Chem Biol Interact. 2018 Aug;291:153-161. DOI: 10.1016/j.cbi.2018.06.027
  78. Selmi S, Rtibi K, Grami D, Sebai H, Marzouki L. Protective effects of orange (Citrus sinensis L.) peel aqueous extract and hesperidin on oxidative stress and peptic ulcer induced by alcohol in rat. Lipids Health Dis. 2017 Aug;16(1):152. DOI: 10.1186/s12944-017-0546-y
  79. Bigoniya P, Singh K. Ulcer protective potential of standardized hesperidin, a citrus flavonoid isolated from Citrus sinensis. Rev Bras Farmacogn. 2014;24(3):330-340. DOI: 10.1016/j.bjp.2014.07.011
  80. Acipayam C, Bayram I, Daglioglu K, Doran F, Yilmaz S, Sezgin G, et al. The protective effect of hesperidin on methotrexate-induced intestinal epithelial damage in rats: an experimental study. Med Princ Pract. 2014;23(1):45-52. DOI: 10.1159/000355900
  81. Dağlioğlu YK, Acipayam C, Benc IG, Kibar F, Köksal F. The effectiveness of hesperidin in the prevention of bacterial translocation caused by methotrexate in the gastrointestinal tract. Kafkas Univ Vet Fak Derg. 2013;19(6):985-988. DOI: 10.9775/kvfd.2013.9236
  82. Park HY, Yu JH. Hesperidin enhances intestinal barrier function in Caco-2 cell monolayers via AMPK-mediated tight junction-related proteins. FEBS Open Bio. 2023 Mar;13(3):532-544. DOI: 10.1002/2211-5463.13564
  83. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand including recommended dietary intakes [Internet]. Canberra ACT: National Health and Medical Research Council; 2006 [cited 2022 Jun 9]. 309 p. Available from: https://www.nhmrc.gov.au/sites/default/files/images/nutrient-refererence-dietary-intakes.pdf
  84. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2023. Glutamine; 2023 Oct [cited 2023 Nov 3]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=878
  85. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015. 631-643 p.
  86. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint WHO/FAO/UNU expert consultation (WHO technical report series; no. 935) [Internet]. Geneva; World Health Organization; 2007 [cited 2023 Nov 3]. 265 p. Available from: https://iris.who.int/bitstream/handle/10665/43411/WHO?sequence=1
  87. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2023. Collagen peptides; 2023 Jul [cited 2023 Nov 3]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=1606
  88. Abrahams M, O'Grady R, Prawitt J. Effect of a daily collagen peptide supplement on digestive symptoms in healthy women: 2-phase mixed methods study. JMIR Form Res. 2022 May;6(5):e36339. DOI: 10.2196/36339
  89. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015. 1197-1223 p.
  90. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2023. Vitamin D; 2023 Oct [cited 2023 Nov 3]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=929
  91. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015.
  92. Examine. Vitamin K [Internet]. Toronto: Examine; 2022 [cited 2023 Jul 6]. Available from: https://examine.com/supplements/vitamin-k/
  93. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2022. Vitamin K; 2023 May [cited 2023 Jul 6]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=983
  94. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand including recommended dietary intakes [Internet]. Canberra ACT: National Health and Medical Research Council; 2006 [cited 2022 Jun 9]. 309 p. Available from: https://www.nhmrc.gov.au/sites/default/files/images/nutrient-refererence-dietary-intakes.pdf
  95. Government of Canada. Antioxidants [Internet]. Ottawa: Government of Canada; 2022 [cited 2023 Nov 9]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=antiox&lang=eng
  96. Efthymakis K, Neri M. The role of zinc L-carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clin Res Hepatol Gastroenterol. 2022;46(7):101954. DOI: 10.1016/j.clinre.2022.101954
  97. Mahmoud A, Abuelazm M, Ahmed AAS, Abdalshafy H, Abdelazeem B, Brašić JR. Efficacy and safety of polaprezinc-based therapy versus the standard triple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022 Oct;14(19):4126. DOI: 10.3390/nu14194126
  98. Shen W, Zhao X, Han Z, Miao Y, Huang H, Zhang Z, et al. Efficacy and safety of polaprezinc in the treatment of gastric ulcer: a multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial. Med Eng Phys. 2022 Dec;110:103860. DOI: 10.1016/j.medengphy.2022.103860
  99. Hond ED, Peeters M, Hiele M, Bulteel V, Ghoos Y, Rutgeerts P. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Aliment Pharmacol Ther. 1999 May;13(5):679-685. DOI: 10.1046/j.1365-2036.1999.00523.x
  100. Lima AAM, Anstead GM, Zhang Q, Figueiredo ÍL, Soares AM, Mota RMS, et al. Effects of glutamine alone or in combination with zinc and vitamin A on growth, intestinal barrier function, stress and satiety-related hormones in Brazilian shantytown children. Clinics (Sao Paulo). 2014;69(4):225-233. DOI: 10.6061/clinics/2014(04)02
  101. Benjamin J, Makharia G, Ahuja V, Anand Rajan KD, Kalaivani M, Gupta SD, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial. Dig Dis Sci. 2012 Apr;57(4):1000-1012. DOI: 10.1007/s10620-011-1947-9
  102. Valvano M, Magistroni M, Cesaro N, Carlino G, Monaco S, Fabiani S, et al. Effectiveness of vitamin D supplementation on disease course in inflammatory bowel disease patients: systematic review with meta-analysis. Inflamm Bowel Dis. 2022 Dec:izac253. DOI: 10.1093/ibd/izac253
  103. Isaac HA, Benjamin S, MK S, Munshi R, Furtado D. Enteral/oral glutamine supplementation in patients following abdominal surgery. Indian J Nutr Diet. 2015;52(3):304-312.
  104. Pugh JN, Sage S, Hutson M, Doran DA, Fleming SC, Highton J, et al. Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner. Eur J Appl Physiol. 2017 Dec;117(12):2569-2577. DOI: 10.1007/s00421-017-3744-4
  105.  Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001 Jan;48(1):28-33. DOI: 10.1136/gut.48.1.28
  106. Tang G, Huang W, Zhang L, Wei Z. Role of glutamine in the management of oral mucositis in patients with cancer: a meta-analysis of randomized controlled trials. Nutr Cancer. 2022;74(2):482-495. DOI: 10.1080/01635581.2021.1889623
  107. Chang SC, Lai YC, Hung JC, Chang CY. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer. Medicine (Baltimore). 2019 Feb;98(8):e14463. DOI: 10.1097/MD.0000000000014463
  108. Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, et al. Glutamine supplementation enhances the effects of a low FODMAP diet in irritable bowel syndrome management. Front Nutr. 2021;8:746703. DOI: 10.3389/fnut.2021.746703
  109. Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019 Jun;68(6):996-1002. DOI: 10.1136/gutjnl-2017-315136
  110. Huang H, Lu L, Chen Y, Zeng Y, Xu C. The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutr J. 2022 May;21(1):24. DOI: 10.1186/s12937-022-00777-x
  111. Abrahams M, O'Grady R, Prawitt J. Effect of a daily collagen peptide supplement on digestive symptoms in healthy women: 2-phase mixed methods study. JMIR Form Res. 2022 May;6(5):e36339. DOI: 10.2196/36339
  112. Charoenngam N, Shirvani A, Kalajian TA, Song A, Holick MF. The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: a randomized, double-blinded, dose-response study. anticancer res. 2020 Jan;40(1):551-556. DOI: 10.21873/anticanres.13984
  113. Zhang Y, Liu L, Wei C, Wang X, Li R, Xu X, et al. Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites. BMC Med. 2023 May;21(1):174. DOI: 10.1186/s12916-023-02880-0
  114. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2023. Vitamin D; 2023 Oct [cited 2023 Nov 3]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=929
  115. Braun L, Cohen M. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015.
  116. Examine. Vitamin K [Internet]. Toronto: Examine; 2022 [cited 2023 Jul 6]. Available from: https://examine.com/supplements/vitamin-k/
  117. Natural Medicines Database [Internet]. Denver CO: TRC Healthcare; 2022. Vitamin K; 2023 May [cited 2023 Jul 6]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=983
  118. Government of Canada. Antioxidants [Internet]. Ottawa: Government of Canada; 2022 [cited 2023 Nov 9]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=antiox&lang=eng
  119. Mahmoud A, Abuelazm M, Ahmed AAS, Abdalshafy H, Abdelazeem B, Brašić JR. Efficacy and safety of polaprezinc-based therapy versus the standard triple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022 Oct;14(19):4126. DOI: 10.3390/nu14194126
  120. Shen W, Zhao X, Han Z, Miao Y, Huang H, Zhang Z, et al. Efficacy and safety of polaprezinc in the treatment of gastric ulcer: a multicenter, randomized, double-blind, double-dummy, positive-controlled clinical trial. Med Eng Phys. 2022 Dec;110:103860. DOI: 10.1016/j.medengphy.2022.103860
  121. Hond ED, Peeters M, Hiele M, Bulteel V, Ghoos Y, Rutgeerts P. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans. Aliment Pharmacol Ther. 1999 May;13(5):679-685. DOI: 10.1046/j.1365-2036.1999.00523.x
  122. Lima AAM, Anstead GM, Zhang Q, Figueiredo ÍL, Soares AM, Mota RMS, et al. Effects of glutamine alone or in combination with zinc and vitamin A on growth, intestinal barrier function, stress and satiety-related hormones in Brazilian shantytown children. Clinics (Sao Paulo). 2014;69(4):225-233. DOI: 10.6061/clinics/2014(04)02
  123. Benjamin J, Makharia G, Ahuja V, Anand Rajan KD, Kalaivani M, Gupta SD, et al. Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial. Dig Dis Sci. 2012 Apr;57(4):1000-1012. DOI: 10.1007/s10620-011-1947-9
  124. Valvano M, Magistroni M, Cesaro N, Carlino G, Monaco S, Fabiani S, et al. Effectiveness of vitamin D supplementation on disease course in inflammatory bowel disease patients: systematic review with meta-analysis. Inflamm Bowel Dis. 2022 Dec:izac253. DOI: 10.1093/ibd/izac253
  125. Isaac HA, Benjamin S, MK S, Munshi R, Furtado D. Enteral/oral glutamine supplementation in patients following abdominal surgery. Indian J Nutr Diet. 2015;52(3):304-312.
  126. Pugh JN, Sage S, Hutson M, Doran DA, Fleming SC, Highton J, et al. Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner. Eur J Appl Physiol. 2017 Dec;117(12):2569-2577. DOI: 10.1007/s00421-017-3744-4
  127. Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001 Jan;48(1):28-33. DOI: 10.1136/gut.48.1.28
  128. Tang G, Huang W, Zhang L, Wei Z. Role of glutamine in the management of oral mucositis in patients with cancer: a meta-analysis of randomized controlled trials. Nutr Cancer. 2022;74(2):482-495. DOI: 10.1080/01635581.2021.1889623
  129. Chang SC, Lai YC, Hung JC, Chang CY. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer. Medicine (Baltimore). 2019 Feb;98(8):e14463. DOI: 10.1097/MD.0000000000014463
  130. Rastgoo S, Ebrahimi-Daryani N, Agah S, Karimi S, Taher M, Rashidkhani B, et al. Glutamine supplementation enhances the effects of a low FODMAP diet in irritable bowel syndrome management. Front Nutr. 2021;8:746703. DOI: 10.3389/fnut.2021.746703
  131. Zhou Q, Verne ML, Fields JZ, Lefante JJ, Basra S, Salameh H, et al. Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut. 2019 Jun;68(6):996-1002. DOI: 10.1136/gutjnl-2017-315136
  132. Huang H, Lu L, Chen Y, Zeng Y, Xu C. The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutr J. 2022 May;21(1):24. DOI: 10.1186/s12937-022-00777-x
  133. Charoenngam N, Shirvani A, Kalajian TA, Song A, Holick MF. The effect of various doses of oral vitamin D3 supplementation on gut microbiota in healthy adults: a randomized, double-blinded, dose-response study. anticancer res. 2020 Jan;40(1):551-556. DOI: 10.21873/anticanres.13984
  134. Zhang Y, Liu L, Wei C, Wang X, Li R, Xu X, et al. Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites. BMC Med. 2023 May;21(1):174. DOI: 10.1186/s12916-023-02880-0
logo

Your one stop destination for education and clinical tools, driven by our purpose to inspire people to live better lives through natural healthcare.

Customer Care or Clinical Support

1300 654 336

or visit www.myintegria.com

© 2025, Integria is a registered trademark of Integria Healthcare (Australia) Pty Ltd

Terms of Use | Privacy | Policies